Rational Design and In-Vivo Validation of Capsid Inhibitors for Enterovirus D68
Pippa Scott2026-10-16T11:19:20+00:00Rational Design and In-Vivo Validation of Capsid Inhibitors for Enterovirus D68 The viral capsid
Rational Design and In-Vivo Validation of Capsid Inhibitors for Enterovirus D68 The viral capsid
Discovery of SMD-6346: A Potent, Selective, and Orally Active SMARCA2 Degrader for Targeting
What is in a structure? Cell Permeability and Solubility of Series of Macrocycles and
Spiro-Azetidine Oxindoles as Long-Acting Injectables for Pre-Exposure Prophylaxis against Respiratory Syncytial Virus Infections J.
Structure-Guided Discovery of Selective Polo-Like Kinase 3 inhibitors ACS Med. Chem. Lett. 2026
The Affinity Advantage J. Med. Chem. 2026, 69, 3, 1963–1969 To start with,
Do Amino-Oxetanes Resemble Amides? A Matched Molecular Pairs Property and Structural Comparison J.
Design, modular synthesis and screening of 58 shape-diverse 3-D fragments Fragment
Discovery of the Clinical Candidate S‑892216: A Second-Generation of SARS-CoV‑2 3CL Protease Inhibitor for
Efficient Crystallization of Apo Sirt2 for Small-Molecule Soaking and Structural Analysis of Ligand Interactions
There are two parts to our business – Software and Consulting. Get in touch today to find out how we can help you save time and money.
© 2026 MedChemica • All rights reserved.
41 Avada Avenue, Florida, 98765
403-904-3623